_id
6915ee4fbc934aba376b1e97
Ticker
RGBP
Name
Regen BioPharma Inc
Exchange
PINK
Address
4700 Spring Street, La Mesa, CA, United States, 91942
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://regenbiopharmainc.com
Description
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also developing HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. Regen BioPharma was incorporated in 2012 and is based in La Mesa, California.
Last Close
0.0095
Volume
315312
Current Price
0.0058
Change
-10.526315789473676
Last Updated
2026-01-06T10:12:45.785Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
918465
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9965
Sentiment Sources
2
Current Quarter
2025-06-30
Revenue
59065
Cost Of Revenue
-
Gross Profit
59065
Operating Expenses
99821
Operating Income
-40756
Interest Expense
37277
Pretax Income
-167292
Net Income
-167292
Eps
-0.007043130522733054
Dividends Per Share
-
Shares Outstanding
108054704
Income Tax Expense
-
EBITDA
-130015
Operating Margin
-69.00194700753407
Total Other Income Expense Net
-126536
Cash
1761
Short Term Investments
-
Receivables
177147
Inventories
-
Total Current Assets
179108
Property Plant Equipment
-
Total Assets
196841
Payables
30477
Short Term Debt
1036244
Long Term Debt
-
Total Liabilities
6012532
Equity
-5815691
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
20170
Cash From Operations
-55977
Capital Expenditures
3
Cash From Investing
-
Cash From Financing
55976
Net Change In Cash
0
Cf_currency_symbol
USD
PE
-
PB
-0.023688420653710796
ROE
2.876562733473976
ROA
-84.98839164604935
FCF
-55980
Fcf Percent
-0.9477694065859646
Piotroski FScore
1
Health Score
18
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
3
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
59065
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
59065
Quarters > 0 > income Statement > operating Expenses
99821
Quarters > 0 > income Statement > operating Income
-40756
Quarters > 0 > income Statement > interest Expense
37277
Quarters > 0 > income Statement > pretax Income
-167292
Quarters > 0 > income Statement > net Income
-167292
Quarters > 0 > income Statement > eps
-0.007043130522733054
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
23752506
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-130015
Quarters > 0 > income Statement > operating Margin
-69.00194700753407
Quarters > 0 > income Statement > total Other Income Expense Net
-126536
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1761
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
177147
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
179108
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
196841
Quarters > 0 > balance Sheet > payables
30477
Quarters > 0 > balance Sheet > short Term Debt
1036244
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6012532
Quarters > 0 > balance Sheet > equity
-5815691
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-167294
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
20170
Quarters > 0 > cash Flow > cash From Operations
-55977
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
55976
Quarters > 0 > cash Flow > net Change In Cash
0
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.007043130522733054
Quarters > 0 > ratios > PB
-0.023688420653710796
Quarters > 0 > ratios > ROE
2.876562733473976
Quarters > 0 > ratios > ROA
-84.98839164604935
Quarters > 0 > ratios > FCF
-55980
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.9477694065859646
Quarters > 0 > health Score
18
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
59065
Quarters > 1 > income Statement > cost Of Revenue
59065
Quarters > 1 > income Statement > gross Profit
59065
Quarters > 1 > income Statement > operating Expenses
172414
Quarters > 1 > income Statement > operating Income
-113349
Quarters > 1 > income Statement > interest Expense
34968
Quarters > 1 > income Statement > pretax Income
-19354
Quarters > 1 > income Statement > net Income
-19354
Quarters > 1 > income Statement > eps
-0.0008979014511171204
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
21554704
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
15614
Quarters > 1 > income Statement > operating Margin
-191.90552780834673
Quarters > 1 > income Statement > total Other Income Expense Net
93995
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1761
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
149723
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
151749
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
169482
Quarters > 1 > balance Sheet > payables
33703
Quarters > 1 > balance Sheet > short Term Debt
967632
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5867881
Quarters > 1 > balance Sheet > equity
-5698399
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-19355
Quarters > 1 > cash Flow > depreciation
61378
Quarters > 1 > cash Flow > change In Working Capital
-94514
Quarters > 1 > cash Flow > cash From Operations
-101230
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
102856
Quarters > 1 > cash Flow > net Change In Cash
1626
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.0008979014511171204
Quarters > 1 > ratios > PB
-0.021939018871791883
Quarters > 1 > ratios > ROE
0.3396392565701349
Quarters > 1 > ratios > ROA
-11.419501775999812
Quarters > 1 > ratios > FCF
-101230
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.7138745449928046
Quarters > 1 > health Score
15
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
59065
Quarters > 2 > income Statement > cost Of Revenue
59065
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
131602
Quarters > 2 > income Statement > operating Income
-72537
Quarters > 2 > income Statement > interest Expense
37991
Quarters > 2 > income Statement > pretax Income
-460815
Quarters > 2 > income Statement > net Income
-460815
Quarters > 2 > income Statement > eps
-0.028913205670543365
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
15937873
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-422824
Quarters > 2 > income Statement > operating Margin
-122.80876999915347
Quarters > 2 > income Statement > total Other Income Expense Net
-388278
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
135
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
122298
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
179052
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
196785
Quarters > 2 > balance Sheet > payables
36005
Quarters > 2 > balance Sheet > short Term Debt
873137
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5797913
Quarters > 2 > balance Sheet > equity
-5601129
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-460815
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
376593
Quarters > 2 > cash Flow > cash From Operations
-66380
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
65799
Quarters > 2 > cash Flow > net Change In Cash
-581
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.028913205670543365
Quarters > 2 > ratios > PB
-0.016503755475012268
Quarters > 2 > ratios > ROE
8.227180627334238
Quarters > 2 > ratios > ROA
-234.17181187590518
Quarters > 2 > ratios > FCF
-66380
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.1238466096673156
Quarters > 2 > health Score
22
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
59366
Quarters > 3 > income Statement > cost Of Revenue
59366
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
145736
Quarters > 3 > income Statement > operating Income
-86370
Quarters > 3 > income Statement > interest Expense
181516
Quarters > 3 > income Statement > pretax Income
-264899
Quarters > 3 > income Statement > net Income
-264899
Quarters > 3 > income Statement > eps
-0.02971984703140353
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
8913202
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-83383
Quarters > 3 > income Statement > operating Margin
-145.48731597210525
Quarters > 3 > income Statement > total Other Income Expense Net
-178529
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
716
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
159878
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
177611
Quarters > 3 > balance Sheet > payables
29669
Quarters > 3 > balance Sheet > short Term Debt
793699
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5371640
Quarters > 3 > balance Sheet > equity
-5194029
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-264899
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-52037
Quarters > 3 > cash Flow > cash From Operations
-148895
Quarters > 3 > cash Flow > capital Expenditures
5
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
87761
Quarters > 3 > cash Flow > net Change In Cash
-61133
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.02971984703140353
Quarters > 3 > ratios > PB
-0.00995307719691207
Quarters > 3 > ratios > ROE
5.10006778937892
Quarters > 3 > ratios > ROA
-149.14560472042834
Quarters > 3 > ratios > FCF
-148900
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-2.508169659401004
Quarters > 3 > health Score
19
Annuals > 0 > quarter
2025-09-30
Annuals > 0 > income Statement > revenue
126560
Annuals > 0 > income Statement > cost Of Revenue
90000
Annuals > 0 > income Statement > gross Profit
36560
Annuals > 0 > income Statement > operating Expenses
485101
Annuals > 0 > income Statement > operating Income
-338540
Annuals > 0 > income Statement > interest Expense
-158286
Annuals > 0 > income Statement > pretax Income
-1274502
Annuals > 0 > income Statement > net Income
-1274502
Annuals > 0 > income Statement > eps
-0.05418347187756808
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
23521970
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-338540
Annuals > 0 > income Statement > operating Margin
-267.49367888748424
Annuals > 0 > income Statement > total Other Income Expense Net
-935962
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
716
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
94873
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
143351
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
161084
Annuals > 0 > balance Sheet > payables
29669
Annuals > 0 > balance Sheet > short Term Debt
793699
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5378456
Annuals > 0 > balance Sheet > equity
-5217373
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-1274502
Annuals > 0 > cash Flow > depreciation
52148
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-383591
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
452430
Annuals > 0 > cash Flow > net Change In Cash
68839
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.05418347187756808
Annuals > 0 > ratios > PB
-0.03967386192246558
Annuals > 0 > ratios > ROE
24.42804070170946
Annuals > 0 > ratios > ROA
-791.2033473218942
Annuals > 0 > ratios > FCF
-383591
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-3.030902338811631
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2024-09-30
Annuals > 1 > income Statement > revenue
236560
Annuals > 1 > income Statement > cost Of Revenue
77215
Annuals > 1 > income Statement > gross Profit
159345
Annuals > 1 > income Statement > operating Expenses
577534
Annuals > 1 > income Statement > operating Income
-418189
Annuals > 1 > income Statement > interest Expense
72445
Annuals > 1 > income Statement > pretax Income
-867252
Annuals > 1 > income Statement > net Income
-867252
Annuals > 1 > income Statement > eps
-0.0972997133914389
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
8913202
Annuals > 1 > income Statement > income Tax Expense
-867252
Annuals > 1 > income Statement > EBITDA
-418189
Annuals > 1 > income Statement > operating Margin
-176.77925262089954
Annuals > 1 > income Statement > total Other Income Expense Net
-449063
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
716
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
94873
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
159878
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
177611
Annuals > 1 > balance Sheet > payables
29669
Annuals > 1 > balance Sheet > short Term Debt
814699
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5371640
Annuals > 1 > balance Sheet > equity
-5194029
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-867252
Annuals > 1 > cash Flow > depreciation
28998
Annuals > 1 > cash Flow > change In Working Capital
-254384
Annuals > 1 > cash Flow > cash From Operations
-693141
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
572819
Annuals > 1 > cash Flow > net Change In Cash
-120322
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.0972997133914389
Annuals > 1 > ratios > PB
-0.01510122057462521
Annuals > 1 > ratios > ROE
16.697095838317423
Annuals > 1 > ratios > ROA
-488.2873245463401
Annuals > 1 > ratios > FCF
-693141
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.9300853905985798
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2023-09-30
Annuals > 2 > income Statement > revenue
236560
Annuals > 2 > income Statement > cost Of Revenue
60000
Annuals > 2 > income Statement > gross Profit
236560
Annuals > 2 > income Statement > operating Expenses
923510
Annuals > 2 > income Statement > operating Income
-687000
Annuals > 2 > income Statement > interest Expense
309448
Annuals > 2 > income Statement > pretax Income
1157000
Annuals > 2 > income Statement > net Income
1024000
Annuals > 2 > income Statement > eps
0.14475544246536612
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
7074000
Annuals > 2 > income Statement > income Tax Expense
442447
Annuals > 2 > income Statement > EBITDA
3119000
Annuals > 2 > income Statement > operating Margin
-290.41258031788976
Annuals > 2 > income Statement > total Other Income Expense Net
1843000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
121037
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
0
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
131037
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
353617
Annuals > 2 > balance Sheet > payables
29674
Annuals > 2 > balance Sheet > short Term Debt
606590
Annuals > 2 > balance Sheet > long Term Debt
149614
Annuals > 2 > balance Sheet > total Liabilities
5457617
Annuals > 2 > balance Sheet > equity
-5104000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
1156507
Annuals > 2 > cash Flow > depreciation
864
Annuals > 2 > cash Flow > change In Working Capital
-1928511
Annuals > 2 > cash Flow > cash From Operations
-173917
Annuals > 2 > cash Flow > capital Expenditures
3
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
243750
Annuals > 2 > cash Flow > net Change In Cash
69833
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.14475544246536612
Annuals > 2 > ratios > PB
-0.012196551724137932
Annuals > 2 > ratios > ROE
-20.06269592476489
Annuals > 2 > ratios > ROA
289.57883812147037
Annuals > 2 > ratios > FCF
-173920
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.7352045992560027
Annuals > 2 > health Score
39
Annuals > 3 > quarter
2022-09-30
Annuals > 3 > income Statement > revenue
235517
Annuals > 3 > income Statement > cost Of Revenue
50000
Annuals > 3 > income Statement > gross Profit
185517
Annuals > 3 > income Statement > operating Expenses
575122
Annuals > 3 > income Statement > operating Income
-340000
Annuals > 3 > income Statement > interest Expense
255287
Annuals > 3 > income Statement > pretax Income
2444000
Annuals > 3 > income Statement > net Income
2227000
Annuals > 3 > income Statement > eps
0.7101403061224489
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3136000
Annuals > 3 > income Statement > income Tax Expense
-3046000
Annuals > 3 > income Statement > EBITDA
2993000
Annuals > 3 > income Statement > operating Margin
-144.3632519096286
Annuals > 3 > income Statement > total Other Income Expense Net
2783000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
51204
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
254273
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
336422
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
559002
Annuals > 3 > balance Sheet > payables
28799
Annuals > 3 > balance Sheet > short Term Debt
1274050
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8595061
Annuals > 3 > balance Sheet > equity
-8036059
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
2443531
Annuals > 3 > cash Flow > depreciation
71067
Annuals > 3 > cash Flow > change In Working Capital
-3137415
Annuals > 3 > cash Flow > cash From Operations
-606921
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
25000
Annuals > 3 > cash Flow > cash From Financing
-94036
Annuals > 3 > cash Flow > net Change In Cash
-675958
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.7101403061224489
Annuals > 3 > ratios > PB
-0.0034341211282794214
Annuals > 3 > ratios > ROE
-27.712588969294526
Annuals > 3 > ratios > ROA
398.38855674934973
Annuals > 3 > ratios > FCF
-606921
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.576973212124815
Annuals > 3 > health Score
39
Valuation > metrics > PE
-0.007043130522733054
Valuation > metrics > PB
-0.023688420653710796
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
2.876562733473976
Profitability > metrics > ROA
-93.40286307702615
Profitability > metrics > Net Margin
-2.832337255565902
Profitability > final Score
6
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.093328325777289
Risk > final Score
26
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.16790519732901105
Liquidity > metrics > Quick Ratio
0.16790519732901105
Liquidity > final Score
18
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
1
Prev Profitabilities > 1
16
Prev Profitabilities > 2
10
Prev Risks > 0
17
Prev Risks > 1
22
Prev Risks > 2
28
Prev Liquidities > 0
18
Prev Liquidities > 1
20
Prev Liquidities > 2
20
Updated At
2026-01-20T22:28:58.601Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-06-30
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.007
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-16
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.13
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-01-17
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0289
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-10-28
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.03
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-08-13
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0278
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-04-24
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0311
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2024-03-07
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0973
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-11-20
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0799
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-07-25
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0293
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-04-18
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.03
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-12-31
Earnings History > 10 > report Date
2023-01-19
Earnings History > 10 > date
2022-12-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.65
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-11-15
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0201
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-07-22
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.01
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-04-21
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-12-31
Earnings History > 14 > report Date
2022-01-20
Earnings History > 14 > date
2021-12-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.0005
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-12-22
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0003
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-08-04
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0003
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-03-31
Earnings History > 17 > report Date
2021-06-21
Earnings History > 17 > date
2021-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0021
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-12-31
Earnings History > 18 > report Date
2021-03-31
Earnings History > 18 > date
2020-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.0002
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-09-30
Earnings History > 19 > report Date
2020-12-31
Earnings History > 19 > date
2020-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.0008
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-06-30
Earnings History > 20 > report Date
2020-09-30
Earnings History > 20 > date
2020-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.0011
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-03-31
Earnings History > 21 > report Date
2020-06-30
Earnings History > 21 > date
2020-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.0016
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0.0016
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-12-31
Earnings History > 22 > report Date
2020-03-31
Earnings History > 22 > date
2019-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0026
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-09-30
Earnings History > 23 > report Date
2019-10-24
Earnings History > 23 > date
2019-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.05
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-08-29
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
0.0003
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-03-31
Earnings History > 25 > report Date
2019-06-30
Earnings History > 25 > date
2019-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0513
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-12-31
Earnings History > 26 > report Date
2019-02-12
Earnings History > 26 > date
2018-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.0011
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-09-30
Earnings History > 27 > report Date
2018-12-27
Earnings History > 27 > date
2018-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.01
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-06-30
Earnings History > 28 > report Date
2018-08-06
Earnings History > 28 > date
2018-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.006
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-03-31
Earnings History > 29 > report Date
2018-05-14
Earnings History > 29 > date
2018-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.01
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2017-12-31
Earnings History > 30 > report Date
2018-01-05
Earnings History > 30 > date
2017-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.01
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-09-30
Earnings History > 31 > report Date
2017-12-31
Earnings History > 31 > date
2017-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.0195
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-06-30
Earnings History > 32 > report Date
2017-08-07
Earnings History > 32 > date
2017-06-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.02
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-03-31
Earnings History > 33 > report Date
2017-05-04
Earnings History > 33 > date
2017-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.01
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2016-12-31
Earnings History > 34 > report Date
2017-03-31
Earnings History > 34 > date
2016-12-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.0093
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2016-09-30
Earnings History > 35 > report Date
2016-12-31
Earnings History > 35 > date
2016-09-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.0039
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-06-30
Earnings History > 36 > report Date
2016-09-30
Earnings History > 36 > date
2016-06-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.0072
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-03-31
Earnings History > 37 > report Date
2016-06-30
Earnings History > 37 > date
2016-03-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.0078
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2015-12-31
Earnings History > 38 > report Date
2016-03-31
Earnings History > 38 > date
2015-12-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.0058
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2015-09-30
Earnings History > 39 > report Date
2015-12-31
Earnings History > 39 > date
2015-09-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.0059
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2015-06-30
Earnings History > 40 > report Date
2015-09-30
Earnings History > 40 > date
2015-06-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.0046
Earnings History > 40 > eps Estimate
-
Earnings History > 40 > eps Difference
0
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-03-31
Earnings History > 41 > report Date
2015-06-30
Earnings History > 41 > date
2015-03-31
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.0075
Earnings History > 41 > eps Estimate
-
Earnings History > 41 > eps Difference
0
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2014-12-31
Earnings History > 42 > report Date
2015-03-31
Earnings History > 42 > date
2014-12-31
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.0088
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
-0.0088
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2014-09-30
Earnings History > 43 > report Date
2014-12-31
Earnings History > 43 > date
2014-09-30
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-0.0042
Earnings History > 43 > eps Estimate
-
Earnings History > 43 > eps Difference
0
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2014-06-30
Earnings History > 44 > report Date
2014-09-30
Earnings History > 44 > date
2014-06-30
Earnings History > 44 > before After Market
-
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-0.002
Earnings History > 44 > eps Estimate
0
Earnings History > 44 > eps Difference
-0.002
Earnings History > 44 > surprise Percent
-
Earnings History > 45 > period
2014-03-31
Earnings History > 45 > report Date
2014-06-30
Earnings History > 45 > date
2014-03-31
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
USD
Earnings History > 45 > eps Actual
-0.0032
Earnings History > 45 > eps Estimate
0
Earnings History > 45 > eps Difference
-0.0032
Earnings History > 45 > surprise Percent
-
Earnings History > 46 > period
2013-12-31
Earnings History > 46 > report Date
2014-03-31
Earnings History > 46 > date
2013-12-31
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
USD
Earnings History > 46 > eps Actual
-0.0036
Earnings History > 46 > eps Estimate
0
Earnings History > 46 > eps Difference
-0.0036
Earnings History > 46 > surprise Percent
-
Earnings History > 47 > period
2013-09-30
Earnings History > 47 > report Date
2013-12-31
Earnings History > 47 > date
2013-09-30
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
USD
Earnings History > 47 > eps Actual
-0.004
Earnings History > 47 > eps Estimate
0
Earnings History > 47 > eps Difference
-0.004
Earnings History > 47 > surprise Percent
-
Earnings History > 48 > period
2013-06-30
Earnings History > 48 > report Date
2013-09-30
Earnings History > 48 > date
2013-06-30
Earnings History > 48 > before After Market
-
Earnings History > 48 > currency
USD
Earnings History > 48 > eps Actual
-0.0023
Earnings History > 48 > eps Estimate
0
Earnings History > 48 > eps Difference
-0.0023
Earnings History > 48 > surprise Percent
-
Earnings History > 49 > period
2013-03-31
Earnings History > 49 > report Date
2013-06-30
Earnings History > 49 > date
2013-03-31
Earnings History > 49 > before After Market
-
Earnings History > 49 > currency
USD
Earnings History > 49 > eps Actual
-0.0031
Earnings History > 49 > eps Estimate
0
Earnings History > 49 > eps Difference
-0.0031
Earnings History > 49 > surprise Percent
-
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also developing HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. Regen BioPharma was incorporated in 2012 and is based in La Mesa, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 9
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Regen BioPharma Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.007
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.